Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Basic & Clinical Pharmacology & Toxicology
|
August 20, 2025
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients
Kristie Rebecca Weir, Clémentine Tombez, Yvonne Mattmann, et al.
European Journal of Gastroenterology & Hepatology
|
November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Nutrients
|
December 17, 2024
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial
Luc Biedermann, Michael Doulberis, Philipp Schreiner, et al.
Inflammatory Intestinal Diseases
|
July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases
|
April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Stephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Journal of Crohn'S & Colitis
|
September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón, Axel Dignass, Vito Annese, et al.
BMJ Open
|
January 20, 2025
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care
Angela Edith Schulthess-Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, et al.
Journal of Crohn'S & Colitis
|
November 29, 2015
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord, Vito Annese, Stephan R Vavricka, et al.
Lancet (London, England)
|
June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Silvio Danese, Séverine Vermeire, Wen Zhou, et al.
Elife
|
October 5, 2017
The ESRP1-GPR137 axis contributes to intestinal pathogenesis
Lukas Franz Mager, Viktor Hendrik Koelzer, Regula Stuber, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Basic & Clinical Pharmacology & Toxicology
|
August 20, 2025
Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co-Design Approach With General Practitioners and Patients
Kristie Rebecca Weir, Clémentine Tombez, Yvonne Mattmann, et al.
European Journal of Gastroenterology & Hepatology
|
November 1, 2022
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, et al.
Nutrients
|
December 17, 2024
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial
Luc Biedermann, Michael Doulberis, Philipp Schreiner, et al.
Inflammatory Intestinal Diseases
|
July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)
Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases
|
April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Stephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Journal of Crohn'S & Colitis
|
September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón, Axel Dignass, Vito Annese, et al.
BMJ Open
|
January 20, 2025
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care
Angela Edith Schulthess-Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, et al.
Journal of Crohn'S & Colitis
|
November 29, 2015
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord, Vito Annese, Stephan R Vavricka, et al.
Lancet (London, England)
|
June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Silvio Danese, Séverine Vermeire, Wen Zhou, et al.
Elife
|
October 5, 2017
The ESRP1-GPR137 axis contributes to intestinal pathogenesis
Lukas Franz Mager, Viktor Hendrik Koelzer, Regula Stuber, et al.
Page
of 11